Hutch News

Hutch News

Stories tagged 'Sunil Hingorani'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 4, 2016 | By Fred Hutch News Service staff

Drs. Marie Bleakley and Soheil Meshinchi receive $1M to design targeted immunotherapies for childhood leukemia; pancreatic cancer treatment advancing in clinical trials; novel mathematical model could transform dosage selection for clinical trials; new global initiative for breast cancer has roots in Seattle; Dr. Colin Correnti speaks at inaugural SHIFT 2016

View story >


Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

Therapy using engineered immune cells offers promise for the ‘disease that desperately needs something new’

Oct. 29, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

A certain type of immunotherapy can boost survival from the nearly-always deadly pancreatic cancer by more than 75 percent in mice, a new study finds.

View story >


New treatment doubles progression-free survival in some pancreatic cancer patients

Enzyme lowers pressure inside tumors, allows chemotherapy in

May 29, 2015 | By Susan Keown / Fred Hutch News Service

Combining chemotherapy with an experimental enzyme that lowers pressure within tumors seems to double the amount of time certain patients with metastatic pancreatic cancer have before their disease progresses, suggests an interim analysis of data from an ongoing phase 2 trial led by Dr. Sunil Hingorani and colleagues at Fred Hutchinson Cancer Research Center.

View story >


Fred Hutch at ASCO

Research highlights from the annual meeting of the American Society of Clinical Oncology

May 29, 2015 | By Fred Hutch News Service staff

A number of investigators from Fred Hutch will share new research findings at the annual meeting of the American Society of Clinical Oncology, or ASCO, which is being held today through June 2 in Chicago. The theme of this year’s gathering is “Illumination & Innovation: Transforming Data into Learning.”

View story >


Researchers discover tumor molecule that causes spread of pancreatic cancer

Testing could help guide treatment

May 21, 2015 | By Susan Keown / Fred Hutch News Service

Fred Hutch researchers have found that a tumor molecule called RUNX3 acts like a traffic cop of sorts, determining whether pancreatic cancer cells will spread, or metastasize, to distant parts of the body or whether they will stay put. They published their discovery today in the journal Cell.

View story >


Sequestration: 'Wrong cuts at the wrong place at the wrong time'

Sen. Patty Murray visits Fred Hutchinson Cancer Research Center for roundtable discussion with researchers, advocates and former patients on consequences of the sequester on scientific progress, jobs, human lives

April 30, 2013

Sen. Patty Murray visited Fred Hutch to see firsthand how new government spending cuts—called sequestration—may jeopardize the next generation of lifesaving therapies for cancer and other diseases. Murray toured a research lab and heard from more than a half-dozen leading scientists during a roundtable discussion that detailed sequestration's impact.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.